ABSTRACT-A novel murine model of aging (kl /kl mice) has been developed by in vivo mutagenesis. We analyzed endothelial function in this strain. Ring preparations of the thoracic aorta were obtained from 6-to 9-week old wild-type (+ /+) and heterozygous (kl /+) klotho mice. The aortas of kl /+ mice showed an exaggerated contractile response to norepinephrine and attenuated vasodilator responses to acetylcholine and lecithinized superoxide dismutase (SOD) compared to + /+ mice. The response to sodium nitroprusside was unaltered in kl /+ mice. The contraction in response to norepinephrine was augmented by treatment with N G -nitro-L-arginine methyl ester (L-NAME, 10 -5 M) to a greater extent in + /+ mice than in kl /+ mice. Treatment with L-NAME abolished the vasodilator responses to both acetylcholine and lecithinized SOD. NO metabolites (NO2 -and NO3 -) and cGMP concentrations in the urine were significantly reduced in kl /+ mice compared to + /+ mice. However, the urinary excretion of 6-keto-prostaglandin F1= was unaltered. There was little immunostaining for NO synthase and vascular endothelial growth factor (VEGF) in the aorta of kl /+ mice. No immunostaining for NO synthase was noted in the aorta of kl /kl mice. The expression of the klotho gene product may have a role in the regulation of VEGF expression and is tightly linked to endothelial release of NO.
We established a transgenic mouse line in which a gene product was inactivated by homologous recombination with an insertional mutation (1, 2) . This mouse line was identified as a model of aging because several charcteristics of the mouse are typical of the aging process. The affected gene, named klotho, has since been identified (1, 2) .
Defects in klotho gene expression in the mouse result in a syndrome that resembles human aging, including a shortened lifespan, infertility, arteriosclerosis, mitral annular calcification, skin atrophy, osteoporosis, and emphysema (1) . These phenotypes only appear in mice that are homozygous for the transgene (kl /kl mice). One of the most notable histologic changes in the kl /kl mice is the presence of arteriosclerosis. Extensive medial calcification is observed in the aorta. Small arteries in the kidney are also calcified extensively. These vascular changes are very similar to those that occur in human aging. Mice heterozygous for the transgene (kl /+ mice) are similar to wild-type mice (+ /+ mice) and show no phenotype resembling the prematureaging syndrome. The klotho gene encodes a novel cell surface protein of 1014 amino acids (1) . A secretory form of klotho cDNA has also been isolated in humans (2) , but the pathophysiologic role of klotho protein remains to be elucidated.
Established senescence of endothelial cells in culture can be reversed by vascular permeability factor /vascular endothelial growth factor (VPF /VEGF) (3) . VPF/VEGF is highly expressed by a number of different normal cells and tissues in adults in the absence of detectable angiogenesis. As a result, low concentrations of VPF /VEGF are found in normal plasma (4) . One obvious possibility is that VPF /VEGF prevents vascular endothelium from undergoing replicative senescence, thereby maintaining its character-istic latent capacity for replication and ability to produce nitric oxide (NO). Several reports (3, 5) suggest that VPF /VEGF is responsible for these effects, at least in part, by down-regulating the cell cycle-dependent kinase inhibitor, p21.
In the present study, we first examined whether endothelium-dependent NO synthesis is decreased in kl /+ mice. Specifically, we measured endothelium-dependent aortic vasodilation in response to acetylcholine as well as urinary excretion of both NO (NO2 -and NO3 -) and prostacyclin metabolites in + /+ and kl/+ mice. Second, to elucidate the mechanism by which the klotho gene defect induces endothelial dysfunction, immunostaining of the aorta with antiendothelial NO synthase and anti-VEGF antibodies was performed.
MATERIALS AND METHODS

Alterations in endothelium-dependent vascular responses in kl/+ mice
We examined acetylcholine-, norepinephrine-, sodium nitroprusside-and lecithinized superoxide dismutase (lecithinized SOD)-induced responses of aortic rings isolated from kl /+ and + /+ mice (6-to 9-week-old). Aortic rings obtained from kl /kl mice showed complete absence of constriction or dilation due to severe calcification. Cylindrical segments, 1.0-mm-long, were cut from the aorta and were bathed in 10 ml of Krebs bicarbonate saline (120 mmol /L NaCl, 5.2 mmol /L KCl, 2.4 mmol /L CaCl2, 1.2 mmol /L MgSO4, 25 mmol /L NaHCO3, 0.03 mmol /L Na 2 -EDTA and 11 mmol /L dextrose (pH 7.4)) equilibrated with 95% O2 and 5% CO2 and maintained at 37°C.
In a preliminary study, we suspended aortic rings under various levels of resting tension and obtained the optimal vasoconstrictor response to norepinephrine under 0.93 g of tension in both kl /+ and + /+ mice. Thus, the rings were suspended under 0.93 g of tension and preconstricted by adding 10 -7 mol/L norepinephrine. The force of isometric contraction was measured using a force-displacement transducer (Model UR-50GR; Minebea Co., Nagano). After the contraction force had reached a plateau, acetylcholine was added incrementally to the bath to achieve a final bath concentration of 10 -8 to 10 -5 mol /L. The effects of NO synthesis inhibition with N G -nitro-L-arginine methyl ester (L-NAME) at 10 -5 mol/L were also studied. The dose-dependent vasoconstrictor response to norepinephrine (10 -8.5 to 10 -6.5 mol/L) was also determined in the absence and presence of L-NAME (10 -5 mol/L). To confirm that the vascular smooth muscle was intact, the vasodilator response to sodium nitroprusside (10 -10 to 10 -7 mol/L) was determined. The ability of superoxide to shorten the halflife of endothelium-derived NO was also evaluated by administering lecithinized SOD (0.25 to 4.0 units /L) to aortic rings from kl /+ and + /+ mice (6) . To synthesize the lecithinized SOD, 4 molecules of a phosphatidylcholine derivative were covalently bound to a dimer of recombinant human copper-zinc SOD to facilitate tissue penetration.
Acetylcholine (Sigma Chemical Co., St. Louis, MO, USA) and L-NAME (Calbiochem Co., La Jolla, CA, USA) were dissolved in Krebs bicarbonate solution. Norepinephrine (Nor-adrenaline ® ) was a gift of Sankyo Pharmaceutical Co., Tokyo.
In each experimental group, n refers to the number of animals from which the aortic rings were obtained. For vasoconstriction measurements, the maximum response was taken to be the maximum force (mg) induced by norepinephrine (7, 8) . The vasodilator response to each dose of drug is expressed as a percent of the level that preceded the preconstriction induced by norepinephrine (7, 8) .
Determination of the endogenous synthesis of NO and prostacyclin
Animals were fed a laboratory rat chow (Oriental Koubo, Tokyo) that contained 5.5 mEq of sodium and 12.2 mEq of potassium per 100 g of chow. Distilled water (Otsuka Pharmaceutical, Tokyo) lacking inorganic nitrite (NO2 -) or nitrate (NO 3 -) was provided as drinking water. Twentyfour-hour urine samples were collected from all the mice using metabolic cages (Type MM-ST; SGI Co., Tokyo) which could completely separate urine from feces. After the first urine collection, male and female kl /+ or + /+ mice were provided with distilled water or distilled water containing L-NAME at 500 mg/L as drinking water (n = 7 to 8 in each group). The second urine collection was performed 10 days later.
The concentration of NO2 -/NO3 -was determined using an autoanalyzer (TCI-NOX 1000 System; Tokyo Kasei Kogyo, Tokyo). The concentration of NO2 -/NO3 -in rat chow was 0.097 mmol/g. Urinary concentrations of cAMP and cGMP were measured by radioimmunoassay (Cyclic AMP Assay and Cyclic GMP Assay; Yamasa Co., Tokyo). Urinary concentration of 6-keto-prostaglandin F1= (6-keto-PGF 1= ) was also measured by radioimmunoassay (6-keto-PGF1= [
125 I] RIA Kit; Daiichi Pure Chemicals Co., Tokyo).
Tissue localization of endothelial NO synthase and vascular permeability factor/vascular endothelial growth factor immunoreactivity Cross sections (5 mm) of the thoracic aorta from kl /kl, kl /+ or + /+ mice (n = 8 in each group) were immersed in 13% neutral buffered formalin for fixation. The sections were incubated with the rabbit anti-endothelial NO synthase antibody (ECNOS; Transduction Laboratories, Lexington, NY, USA) or rabbit anti-VEGF antibody (VEGF(A-20); Santa Cruz Biotechnology, Los Angeles, CA, USA). The sections were then incubated at 25°C for 60 min with biotin-labeled goat anti-rabbit immunoglobulin G (Vectastain Elite ABC KIT; Vector Laboratories, Burlingame, CA, USA). The sites of peroxidase activity were visualized by incubating the specimens in a solution containing 0.05% 3,3'-diaminobenzidine (Wako Pure Chemical, Tokyo). Sections were counterstained with Mayer's hematoxylin solution (Wako Pure Chemical) and coverslipped. Positive signals of the stained aortic specimens were analyzed with the "freeware" image analysis program NIH image (written by Wayne Rasband at the U.S. National Institutes of Health) using an image scanner. The optical densities were expressed as integrated densities, which were analyzed using a 256-step gray scale to identify positive signals. Using the NIH image program, the signals were quantified as the number of the staining per unit area. The sections were also stained with Hematoxylin-eosin.
Statiststical analyses
Data are reported as the mean ± S.E.M. Differences between data sets were evaluated by performing an analysis of variance (ANOVA), followed by Duncan's multiple range test. A value of P<0.05 was considered statistically significant.
RESULTS
The relaxation of aortic rings induced by acetylcholine was significantly reduced in kl /+ mice compared with + /+ mice (P<0.05, Fig. 1 ). Furthermore, L-NAME abolished the vasodilatory response to acetylcholine in both groups (Fig. 1) . However, no significant difference was observed in the response between the groups after treatment with L-NAME (Fig. 1) . The isometric contraction of aortic rings in response to norepinephrine was greater in kl /+ as compared with + /+ mice (Fig. 1) . Treatment with L-NAME produced a leftward shift in the dose-response curve for norepinephrineinduced vasoconstriction in both groups. However, these changes were more pronounced in + /+ mice. The difference in the vasoconstrictor response to norepinephrine between the two groups was diminished after treatment with L-NAME (Fig. 1) . There was no significant difference in the degree of aortic relaxation in response to sodium nitroprusside between +/+ and kl /+ mice (Fig. 2) .
The relaxation induced by lecithinized SOD was significantly reduced in kl /+ mice compared with + /+ mice (Fig. 2) . L-NAME abolished the vasodilatory responses to lecithinized SOD in both groups. No significant difference was noted in the response to lecithinized SOD between +/+ and kl /+ mice after treatment with L-NAME (Fig. 2) .
The 24-h urine volume and the urinary excretion of creatinine, sodium, and potassium did not differ between the + /+ and kl /+ mice. The urinary excretion of NO 2 -and NO3
-was significantly lower in kl /+ mice (152 ± 16 nmol /day in male kl /+ mice) than in + /+ mice (241 ± 28 nmol /day in male + /+ mice; Fig. 3 ). The urinary excretion of 6-keto-PGF 1= did not differ between kl /+ and + /+ mice (Fig. 3) . While the urinary excretion of cGMP was significantly lower in kl /+ mice (Fig. 3) , the urinary excretion of cAMP did not differ significantly between kl /+ and + /+ mice (Fig. 3) . There was a gender difference in 6-keto-PGF1= and no gender difference in cAMP (Fig. 3) . The administration of L-NAME suppressed the production of NO, as evidenced by decreased concentrations of NO2 -
/NO3
-in the urine. After the administration of L-NAME in the drinking water for 10 days, the urinary excretion of NO2 -and NO3 -was significantly decreased in both + /+ and kl /+ mice. However, the decrease was greater in + /+ than in kl /+ mice (Fig. 4) . Therefore, the NO2 -and NO 3 -urinary excretion did not differ significantly between + /+ and kl /+ mice after oral administration of L-NAME (Fig. 4) .
Hematoxylin-eosin staining showed no detachment of endothelial cells in kl /kl or kl /+ mice (Fig. 5) . Specific endothelial NO synthase immunoreactivity was detected in the aortic endothelium in both the + /+ and kl /+ groups. Focal immunostaining for VPF /VEGF was also demonstrated in the aortic walls in both groups. Immunostaining for NO synthase and VPF /VEGF were weaker in the aortas of kl /+ mice than in the aortas of + /+ mice (Fig. 5) . Almost no immunostaining for NO synthase or VPF /VEGF was noted in kl /kl mice (Fig. 5) . The optical density of NO synthase immunostaining in + /+ mice (20.1 ± 1.1 /unit area) was significantly higher than in kl /+ (11.7 ± 1.4 /unit area) and kl /kl mice (0.8 ± 0.3 /unit area). The optical density of VPF/VEGF immunostaining in + /+ mice (27.3 ± 1.9 /unit area) was also significantly higher than in kl /+ (17.3 ± 1.6 /unit area) and kl/kl mice (7.3 ± 0.8 /unit area).
DISCUSSION
In the present study, we have demonstrated that the relaxation of aortic rings in response to acetylcholine is significantly attenuated in kl /+ mice compared to + /+ mice. This result suggests that vascular endothelial function in the aorta is significantly impaired in kl /+ mice. We have also shown that the urinary excretion of NO metabolites in kl /+ mice is significantly decreased compared to + /+ mice. Urinary excretion of NO metabolites reflects the amount of NO derived from vascular endothelium, renal tubular cells and vascular nerves. After treatment with L-NAME, the urinary excretion of NO 2 -and NO 3 -did not differ between kl /+ mice and + /+ mice, indicating that endogenous NO production is significantly reduced in kl /+ mice.
The urinary excretion of cGMP is also reduced in kl /+ mice, which is in keeping with the finding of reduced urinary excretion of NO2
-and NO3 -in kl /+ mice. Tolins et al. (9) have demonstrated that the hemodynamic responses to acetylcholine in the rat correlate well with changes in urinary cGMP concentrations and that pretreatment with L-NAME prevents acetylcholine-induced increases in urinary cGMP excretion. Using urinary cGMP as an indicator of NO synthesis, Shultz and Tolins (10) provided evidence for increased in vivo NO synthesis in response to high dietary salt intake.
In the present study, the more intriguing finding was that the concentration of 6-keto-PGF1= did not differ between kl/+ and + /+ mice. Osanai et al. (11) reported that flowinduced prostacyclin production in cultured endothelial cells is enhanced by NO synthase inhibition. However, flow-induced NO production is unaffected by prostacyclin inhibition by indomethacin. In contrast, Hansen et al. (12) reported that the injection of an NO synthase inhibitor did not change the urinary excretion of 6-keto-PGF1= in healthy volunteers. In the present study, we conclude that specific inhibition of NO synthase occurs in kl/+ mice.
Wakasugi et al. (13) reported that aortic prostacylin synthesis was increased significantly by treatment with estradiol but decreased by treatment with testosterone. They also showed that prostacyclin synthesis by cultured aortic medial smooth muscle cells was significantly increased in the presence of estradiol. In papillary collecting duct cells, Wang et al. demonstrated a significantly higher density of vasopressin V2 receptors and a greater ability of vasopressin to stimulate cyclic AMP accumulation in male than in female rats (14) . These results account for the gender difference in 6-keto-PGF1= and no gender difference in cAMP in the present study.
The klotho gene product may function as part of a humoral signaling pathway that regulates NO synthesis in vivo. However, it must be kept in mind that the klotho gene is expressed mainly in specific cells and tissues, such as renal tubules and the choroid plexus. Previous experiments have demonstrated that the expression of an exogenous klotho gene in limited organs can improve systemic aging phenotypes in kl /kl mice (1). Therefore, we assume that humoral factors may directly or indirectly mediate the pleiotropic functions of the klotho protein. We have also shown that klotho protein itself, or any klotho proteinrelated circulating factor(s), in + /+ mice can be transferred to kl /+ mice by successful parabiosis, resulting in the restoration of endothelial function (15) .
The endothelium modulates vasomotor tone by releasing endothelium-derived NO. This important function of the endothelium is impaired in the presence of several common diseases, including hypercholestrolemia and atherosclerosis (16) . Aging per se contributes to the development of impaired endothelium-dependent dilation in human blood vessels (17) . The mechanism through which klotho gene defects impair NO synthesis is unknown. However, an impaired NO synthesis may possibly initiate the process of extensive medial calcification observed in kl /kl mice. An interesting finding in the present study is the attenuation of the relaxant response to lecithinized SOD in the kl /+ mice. Addition of lecithinized SOD produced more relaxation of aortic rings from + /+ mice compared with those from kl /+ mice. This effect was probably due to inhibition of the inactivation of NO by the superoxide radical generated in the bath (18) . That the decreased relaxation of aortic rings from kl /+ mice after SOD was, indeed, due to decreased NO release, was strengthened by the observation that addition of LNAME to the bath abolished the SOD-induced relaxation by inactivating the NO released by the endothelium (19) .
An alternative explanation for the decreased NO formation in kl /+ mice may be the down-regulation of endothelial NO synthase because of defects in the klotho gene. In fact, NO synthase immunostaining was almost absent in kl /kl mice and weaker in kl /+ mice than in + /+ mice. Like most normal cells, human endothelial cells possess a limited replicative life span; and, after multiple in vitro passages, endothelial cells develop an arrest in cell division referred to as replicative senescence (3). For many cell types, senescence can be delayed by oncogenes or tumor suppressor genes or prevented altogether by malignant transformation. The cytokine VPF /VEGF reportedly delays senescence in human dermal microvascular endothelial cells (3) . Of particular importance, VPF /VEGF is able to rescue senescent human dermal microvascular endothelial cells returning them to a proliferative phase without inducing cell transformation. Furthermore, VPF /VEGF reduces the expression of a senescence marker, neutral beta-galactosidase, and the expression of several cell cyclerelated genes (p21, p16 and p27) in endothelial cells (3) . Therefore, klotho protein may play a role in regulating VPF /VEGF and protect endothelial cells from cellular senescence.
In conclusion, the present study demonstrates that NO synthesis in klotho mice is significantly impaired. The expression of the klotho gene product tightly links endothelial function to NO release. Klotho gene product may regulate NO synthase and VEGF expression and protect endothelial cells from cellular senescence.
